S595-0304 Screening compound: 2-{5-[(benzyloxy)methyl]-1,2,4-oxadiazol-3-yl}-N-[(4-methoxyphenyl)methyl]piperidine-1-carboxamide

S595-0304 Screening compound: 2-{5-[(benzyloxy)methyl]-1,2,4-oxadiazol-3-yl}-N-[(4-methoxyphenyl)methyl]piperidine-1-carboxamide
S595-0304 Screening compound: 2-{5-[(benzyloxy)methyl]-1,2,4-oxadiazol-3-yl}-N-[(4-methoxyphenyl)methyl]piperidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S595-0304
2-{5-[(benzyloxy)methyl]-1,2,4-oxadiazol-3-yl}-N-[(4-methoxyphenyl)methyl]piperidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S595-0304

Molecular Formula

C24H28N4O4 (C24 H28 N4 O4)

Compound Name

2-{5-[(benzyloxy)methyl]-1,2,4-oxadiazol-3-yl}-N-[(4-methoxyphenyl)methyl]piperidine-1-carboxamide

IUPAC name

2-{5-[(benzyloxy)methyl]-124-oxadiazol-3-yl}-N-[(4-methoxyphenyl)methyl]piperidine-1-carboxamide

SMILES

COc1ccc(CNC(N(CCCC2)C2c2noc(COCc3ccccc3)n2)=O)cc1

InChI

InChI=1S/C24H28N4O4/c1-30-20-12-10-18(11-13-20)15-25-24(29)28-14-6-5-9-21(28)23-26-22(32-27-23)17-31-16-19-7-3-2-4-8-19/h2-4,7-8,10-13,21H,5-6,9,14-17H2,1H3,(H,25,29)/t21-/m0/s1

InChI Key

FKGWZOVEBRFHSG-NRFANRHFSA-N

MDL Number (MFCD)

MFCD31982074

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

436.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.729

Distribution Coefficient, logD

3.729

Water Solubility, LogSw

-4.01

Polar Surface Area

73.773

Acid Dissociation Constant (pKa)

15.86

Base Dissociation Constant (pKb)

-0.18

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

37.50

S595-0304 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S595-0304 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S595-0304?
Check Price and Availability of S595-0304, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S595-0304 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S595-0304
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S595-0304
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S595-0304 available by request